Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc., announced new findings that show MHC-II protein expression is a more reliable predictor of response to pembrolizumab (Keytruda®) than the ...
With the fifth overall pick in the 2024 NBA draft, the Detroit Pistons selected forward Ron Holland II, who last played with the Ignite in the NBA G League. Holland averaged 19.5 points, 6.7 rebounds, ...
Golden, CO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Ignite Proteomics LLC, a subsidiary of IMAC Holdings, Inc. (BACK), today announced the presentation of new data demonstrating that MHC-II protein ...
Ignite Proteomics announced the presentation of new data demonstrating that MHC-II protein expression is a superior predictor of response to pembrolizumab compared to PD-L1 at the upcoming National ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results